Terms: = Thyroid cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Diagnosis
24 results:
1. To diagnose primary and secondary squamous cell carcinoma of the thyroid with ultrasound malignancy risk stratification.
Zhang X; Wei B; Nong L; Zhang H; Zhang J; Ye J
Front Endocrinol (Lausanne); 2023; 14():1238775. PubMed ID: 38495474
[TBL] [Abstract] [Full Text] [Related]
2. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract] [Full Text] [Related]
3. Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.
Nosé V; Gill A; Teijeiro JMC; Perren A; Erickson L
Endocr Pathol; 2022 Mar; 33(1):197-227. PubMed ID: 35285003
[TBL] [Abstract] [Full Text] [Related]
4. [The effect of Hashimoto's thyroiditis on the diagnostic efficacy of ultrasound-guided fine needle aspiration cytology for thyroid nodules ≥ 1 cm].
Hou J; Li M; Peng X; Li Y; Liu L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Sep; 35(9):807-812. PubMed ID: 34628833
[No Abstract] [Full Text] [Related]
5. Presurgical Stratification of thyroid Nodules - Is it really Needed? Current Guidelines versus Real Life.
Borlea A; Dobrescu A; Dema A; Cornianu M; Lazăr FO; Brebu D
Chirurgia (Bucur); 2021; 116(1):66-74. PubMed ID: 33638328
[No Abstract] [Full Text] [Related]
6. Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1.
Hozumi K; Fukuoka H; Odake Y; Takeuchi T; Uehara T; Sato T; Inoshita N; Yoshida K; Matsumoto R; Bando H; Hirota Y; Iguchi G; Taniguchi M; Otsuki N; Nishigori C; Kosaki K; Hasegawa T; Ogawa W; Takahashi Y
Endocr J; 2019 Oct; 66(10):853-857. PubMed ID: 31189769
[TBL] [Abstract] [Full Text] [Related]
7. Acromegaly associated with GIST, non-small cell lung carcinoma, clear cell renal carcinoma, multiple myeloma, medulla oblongata tumour, adrenal adenoma, and follicular thyroid nodules.
Jawiarczyk-Przybyłowska A; Wojtczak B; Whitworth J; Sutkowski K; Bidlingmaier M; Korbonits M; Bolanowski M
Endokrynol Pol; 2019; 70(2):213-217. PubMed ID: 30742299
[TBL] [Abstract] [Full Text] [Related]
8. Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms.
Guerin C; Romanet P; Taieb D; Brue T; Lacroix A; Sebag F; Barlier A; Castinetti F
Endocr Relat Cancer; 2018 Feb; 25(2):T15-T28. PubMed ID: 28874394
[TBL] [Abstract] [Full Text] [Related]
9. Genetics of medullary thyroid cancer: An overview.
Accardo G; Conzo G; Esposito D; Gambardella C; Mazzella M; Castaldo F; Di Donna C; Polistena A; Avenia N; Colantuoni V; Giugliano D; Pasquali D
Int J Surg; 2017 May; 41 Suppl 1():S2-S6. PubMed ID: 28506408
[TBL] [Abstract] [Full Text] [Related]
10. Circulating thyroid stimulating hormone receptor messenger RNA and differentiated thyroid cancer: A diagnostic meta-analysis.
Zhang ZZ; Chen Q; Kong CY; Li ZM; Wang LS
Oncotarget; 2017 Jan; 8(4):6623-6629. PubMed ID: 28036261
[TBL] [Abstract] [Full Text] [Related]
11. Integrating Molecular Testing in the diagnosis and Management of Children with thyroid Lesions.
Ballester LY; Sarabia SF; Sayeed H; Patel N; Baalwa J; Athanassaki I; Hernandez JA; Fang E; Quintanilla NM; Roy A; López-Terrada DH
Pediatr Dev Pathol; 2016; 19(2):94-100. PubMed ID: 26366474
[TBL] [Abstract] [Full Text] [Related]
12. Coexistence of paraganglioma/pheochromocytoma and papillary thyroid carcinoma: a four-case series analysis.
Bugalho MJ; Silva AL; Domingues R
Fam Cancer; 2015 Dec; 14(4):603-7. PubMed ID: 26071763
[TBL] [Abstract] [Full Text] [Related]
13. Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association?
Erdas E; Aste N; Pilloni L; Nicolosi A; Licheri S; Cappai A; Mastinu M; Cetani F; Pardi E; Mariotti S; Pomata M
BMC Cancer; 2012 Dec; 12():614. PubMed ID: 23259638
[TBL] [Abstract] [Full Text] [Related]
14. [Usefulness of the immunohistochemical analysis of several molecular markers in the characterization of papillary thyroid carcinoma with initial lymph node metastasis].
Zafón C; Castellví J; Obiols G
Endocrinol Nutr; 2010 Apr; 57(4):165-9. PubMed ID: 20403734
[TBL] [Abstract] [Full Text] [Related]
15. Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Luo M; Zhan S; Xie K; Ma Y; Li QQ
Int J Biol Markers; 2010; 25(1):38-45. PubMed ID: 20306451
[TBL] [Abstract] [Full Text] [Related]
16. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.
Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH
Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.
Park YJ; Kwak SH; Kim DC; Kim H; Choe G; Park DJ; Jang HC; Park SH; Cho BY; Park SY
J Korean Med Sci; 2007 Aug; 22(4):621-8. PubMed ID: 17728499
[TBL] [Abstract] [Full Text] [Related]
18. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid Rodolico V; Cabibi D; Pizzolanti G; Richiusa P; Gebbia N; Martorana A; Russo A; Amato MC; Galluzzo A; Giordano C
Cancer; 2007 Sep; 110(6):1218-26. PubMed ID: 17685465
[TBL] [Abstract] [Full Text] [Related]
19. A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples.
Denning KM; Smyth PC; Cahill SF; Finn SP; Conlon E; Li J; Flavin RJ; Aherne ST; Guenther SM; Ferlinz A; O'Leary JJ; Sheils OM
Mod Pathol; 2007 Oct; 20(10):1095-102. PubMed ID: 17660800
[TBL] [Abstract] [Full Text] [Related]
20. The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia.
Raphael SJ
Endocr Pathol; 2002; 13(4):301-11. PubMed ID: 12665648
[TBL] [Abstract] [Full Text] [Related]
[Next]
